SAFC wasted no time moving forward in 2012! As we ramp up for our first big show of the year, Informex 2012, we wanted to take some time to run through what we will have to offer leading up to and throughout the upcoming event in New Orleans, LA.
Archive for the ‘Fine Chemicals’ Category
SAFC Gets Ready to Take on the “Big Easy” at Informex 2012!
Tuesday, January 24th, 2012LIVE from CPhI Worldwide: SAFC Announces Safebridge Certification for the Verona, WI Facility
Wednesday, October 26th, 2011Manufacturing Chemist offers a view from the world’s largest pharmaceutical exhibition as SAFC announces Safebridge Certification for the Verona, Wisconsin facility that specializes in High Potency API manufacture (HPAPI).
Read the full story by clicking here.
SAFC Named #6 in CHEManager’s Fine Chemicals: Top 10
Thursday, June 16th, 2011SAFC is pleased to be named as #6 in CHEManager’s recent editorial covering the Top 10 “movers and shakers” in Fine Chemicals. This ranking shows a direct connection to SAFC’s commitment to the “Feel It” campaign which has supported the consistent growth of the company, even through tougher economic times. SAFC strives to maintain a problem solving approach in all customer situations to ensure that they are not only providing quality products to end-users, but also providing a human approach to doing business.
CPhI: Fine Chemicals Are On the Up – Chem Week’s Alex Scott reports….
Friday, October 15th, 2010Top man Alex Scott of Chemical Week was in Paris last week covering CPhI. We caught up with Alex, who spoke to Gilles Cottier as part of his round-up of how the industry is shaping up following the economic downturn seen in 2008 and 2009.
“The outlook for the pharmaceutical fine chemicals market is a positive one, according to a straw poll of exhibitors interviewed by CW at the CPhI pharmaceuticals expo in Paris,” writes Scott. “Generally, the number of contract fine chemical projects going to tender is up, and companies say they are bidding for more pharma fine chemical projects and winning more as well when compared to a year ago.
“SAFC,” continue Scott, “says that the market for easy to make active pharma ingredients (API) is “not completely over the recession. Overall, however, the market is ‘positive,’ says Gilles Cottier, SAFC President, who added that funding for biotech is not where it should be – but we see growth in niche areas including high potency API.”
Read Alex Scott’s full round up here
